chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 54.0
Sex: M
Vaccine: FLU3
Symptoms: Pain in extremity, Tendon injury
Clinical narrative: Case number PHHY2015US032037, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 555295) website on 16 Mar 2015. This report refers to a 54-year-old male patient. The patient's historical conditions and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 145621) ON 28 Oct 2014 into left arm. On an unknown date after vaccination, the patient complained of arm pain. The patient had visited to emergency room and the  MD told the patient that tendon might have been hit during vaccination. The outcome of the events was not recovered. The events was reported as non-serious and causality was not reported.
Age: 53.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Induration, Peripheral swelling
Clinical narrative: Case number PHHY2015US032086, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 555296) website on 16 Mar 2015. This report refers to a 53-year-old male patient. This patient's medical historical conditions and concomitant medications were not reported. This patient had no known drug allergies. The patient was vaccinated with FLUVIRIN (batch number: 146624) intramuscularly into left arm and PNEUMOVAX (batch number: K009105) intramuscularly into right arm on an unspecified date. On 21 Nov 2014, the patient had swelling of the arm and the arm was hard as a brick. The patient had no shortness of breath and rash. The outcome of the events was reported as unknown. The events were reported as non-serious and causality was not reported.
Sex: F
Vaccine: FLU3
Symptoms: Injection site bruising, Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Case number PHHY2015US032101, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 555421) websit4e on 16 Mar 2015. This report refers to a 31 year old female patient. Medical history and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 14512P) intramuscularly on 01 Oct 2014. On the same date, after vaccination the patient had erythema, pruritus, swelling and bruise at injection site. She visited to emergency room. The events were reported as non-serious. The outcome of the events reported as recovered. Causality of the event was not reported.
Age: 66.0
Sex: M
Vaccine: FLU3, PNC13
Symptoms: Muscular weakness, Myalgia
Clinical narrative: Case number PHHY2015US0131956, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 555714) website on 16 Mar 2015. This report refers to a 66-year-old male patient. Historical conditions included hypertension, hyperlipidemia, and inflammation of jaw. Concomitant medication included ZYRTEC, FLONASE, LEVITRA, LYRICA and ibuprofen. He was vaccinated with FLUVIRIN (batch number: 146303) intramuscularly into the left arm on 27 Oct 2014. He was also vaccination with PREVNAR 13 (batch number: J11486) intramuscularly into the right arm on 27 Oct 2014. On 28 Oct 2014, the patient experienced soreness of shoulder girdle muscles, progressive weakness of deltoid, biceps, and triceps muscles. Further, the patient had tenderness of muscle and trapezius muscle of right was tender. The patient required emergency room ((ER) visit. The events were reported as non-serious. Outcome of the events was reported as not recovered. Causality of the events was not reported.
Age: 61.0
Sex: F
Vaccine: FLU3, VARZOS
Symptoms: Injection site bruising, Injection site erythema, Injection site urticaria
Clinical narrative: Case number PHHY2015US9032023 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 555794) web site on 16 Mar 2015. This report refers to a 61 years old female patient. No historical conditions and concomitant medications were reported. She was vaccinated with FLUVIRIN (batch number: 1411821) intramuscularly and ZOSTAVAX (other manufacturer, batch number: K010628) subcutaneously on 23 Nov 2014. The patient noticed hives around injection site the day after administration on 24 Nov 2014. Then bruising developed at site of injection and a red area approximately 2 inches around near injection site. This red area as well as bruising developed day after administration. It was reported that red hives disappeared. The outcome of the events bruising and redness was reported as condition unchanged. The events were reported as non-serious. The causality of the events was not reported.
Age: 46.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Injected limb mobility decreased, Vaccination complication, Vaccination site pain
Clinical narrative: Case number PHHY2015US099808, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 555800) website on 05 Mar 2015. This report refers to a 46-year-old male patient. The patient's medical history included back and was on pain management. Vaccination history included flu vaccination in 2012. Concomitant medications included tizanidine and NORCO. He was vaccinated with FLUVIRIN (batch number 145223) into the left arm on 16 Oct 2014. On 28 Oct 2014, the patient had soreness in the vaccination site which went away after a few days. Later, the patient had left shoulder pain which got to a point that the patient had to see a physician. The patient had trouble in lifting his arm over his head. He went to the emergency room. The patient physician stated that he had an adverse reaction to the vaccination received. The outcome of the events left shoulder pain and trouble in lifting his arm over his head was unknown. The events were assessed as non-serious. The causality assessment of the events was not reported.
Age: 46.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Injected limb mobility decreased, Injection site pain
Clinical narrative: Case number PHHY2015US099808, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 555800) website on 05 Mar 2015. This report refers to a 46-year-old male patient. The patient's medical history included back and was on pain management. Vaccination history included flu vaccination in 2012. Concomitant medications included tizanidine and NORCO. He was vaccinated with FLUVIRIN (batch number 145223) into the left arm on 16 Oct 2014. On 28 Oct 2014, the patient had soreness in the vaccination site which went away after a few days. Later, the patient had left shoulder pain which got to a point that the patient had to see a physician. The patient had trouble in lifting his arm over his head. He went to the emergency room. The patient physician stated that he had an adverse reaction to the vaccination received. The outcome of the events left shoulder pain and trouble in lifting his arm over his head was unknown. The events were assessed as non-serious. The causality assessment of the events was not reported.
Age: 11.0
Sex: M
Vaccine: HPV4, MNQ, TDAP
Symptoms: Dizziness, Vomiting
Clinical narrative: Case number PHHY2015US029899 is an initial spontaneous report received via Vaccine Adverse Event Reporting System (VAERS ID: 555873) on 05 Mar 2015. This report refers to an 11 years old male patient. Historical condition included overweight. The patient was vaccinated with MENVEO (batch number: M14030) into left arm along with GARDASIL (batch number: K00617) and BOOSTRIX (batch number: 5DM34) into right arm on 11 Nov 2014 at 10:00 AM. He did not eat before vaccination. On the same day, after vaccination, the patient vomited and felt dizzy in parking lot. Vital signs were taken temperature 98.2, oxygen 96, pulse 74 and blood pressure was 100/60. The patient sat in the office for 10 minutes and then left. The events outcome was reported as complete recovery. Events were assessed as non-serious. Causality assessment was not provided.
Age: 32.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Feeling abnormal, Malaise, Pain, Pyrexia
Clinical narrative: Case number PHHY2015US029094, is an initial spontaneous report received from a consumer (patient) via the Vaccine Adverse Event Reporting System (VAERS reference number: 555939) website on 05 Mar 2015. This report refers to a 32 year old female patient. The patient was on SPRINTEC a birth control pill for several years. On24 Oct 2014, she was vaccinated with FLUVIRIN (batch number: 1413201) into left arm via intramuscular route. On 24 Nov 2014, she developed fever, chills, total body aches and felt horrible. In response to the event she started treatment with three different antibiotics (unspecified) and oral steroids. Her treating physician thought that she had a reaction to FLUVIRIN as she was sick since the day of vaccine administration. The outcome of the events was reported as condition unchanged. Events were reported as non-serious. Causality assessment was not provided.
Age: 48.0
Sex: F
Vaccine: FLU3
Symptoms: Drug administration error, Exposure to contaminated device, No adverse event
Clinical narrative: Case number PHHY2015US032607 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 555951) website on 16 Mar 2015. This report refers to a 48 years old female patient. Historical conditions and concomitant medication were not reported. She was vaccinated with FLUVIRIN (batch number: 146623) into the left arm on 18 Nov 2014. The patient was injected after needle went into registered pharmacist' (RPh) finger first. She went to the emergency room and requested hepatitis B (other manufacturer, batch number: not reported) shot. No adverse events were reported following the maladministration. The event was reported as non-serious. No further information was provided.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Limb discomfort, Pain in extremity
Clinical narrative: Case number PHHY2015US032601, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 555952) website on 16 Mar 2015. This report refers to a 46 years old female patient. Historical conditions and concomitant medication were none. She was vaccinated with FLUVIRIN (batch number: 1412401) intramuscularly into the left arm on 15 Oct 2014. Two weeks after shot on 01 Nov 2014, the patient experienced soreness and some discomfort from shoulder to elbow. The final outcome of the event was reported as condition unchanged. The events were reported as non-serious. The causality of the events was not reported.
Age: 58.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Peripheral swelling
Clinical narrative: Case number PHHY2015US032566, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 556075) website on 16 Mar 2015. This report refers to a 58 year old female patient. She had arm surgery, one or two weeks prior to vaccination. Current conditions included diabetes, hypertension and hyperlipidemia. Concomitant medications included diabetic medications, hypertensive medications, statins, sleeping pills, anti-anxiety pills and FIORICET. She was vaccinated with FLUVIRIN (batch number: 145205) along with PNEUMOVAX (other manufacturer, batch number: 7002681500), intramuscularly on 22 Oct 2014. On the same date, her arm/shoulder was swollen and she went to emergency room that night. She was prescribed BENADRYL, pain killers and steroid and was sent home. The final outcome of the events reported as complete recovery. The events were reported as non serious. Causality was not reported.
Age: 74.0
Sex: F
Vaccine: FLU3, TDAP
Symptoms: Musculoskeletal pain, Paraesthesia, Rash
Clinical narrative: Case number PHHY2015US032154, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 556542) website on 16 Mar 2015. This report refers to a 74 year old female patient. Historical condition and concomitant medication were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1413501) intramuscularly into right arm and BOOSTRIX (other manufacturer, batch number: 9M9AA) intramuscularly into left arm, both on 16 Oct 2014. On 20 Oct 2014, the patient experienced bilateral shoulder pain. She also experienced tingling on left arm for six weeks and rash on front of the leg (both sides). Outcome of the event rash on front of the leg was reported as resolved; outcome of rest of the events was reported as condition unchanged. The events were reported as non-serious. Causality was not reported.
Age: 55.0
Sex: F
Vaccine: FLU3
Symptoms: Fatigue, Injection site pain, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2015US031934, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 556616) website on 16 Mar 2015. This report refers to a 55 year old female patient. Vaccination history included pneumococcal vaccine on an unknown date and experienced localized reaction at injection site of redness, swelling and hives on legs and trunk and physician did not prescribe a course of treatment. She had not sought out a physician, but had incidents noted in her medical records with her family physician. Historical drugs included extended release medications and serotonin reuptake inhibitors. Concomitant medications included gabapentin, oxycodone, ZANAFLEX, AMBIEN and LIDODERM patch 5%. She was vaccinated with FLUVIRIN (batch number: 66521011702) into the left arm (intramuscular) on 21 Nov 2011. 45 minutes after injection, the patient experienced general malaise and exhaustion which lasted about 18 hours. The patient experienced a reaction at injection site (itching, swelling and heat) and she had itching in left arm, at areas of head and scalp. She experienced localized area pain at injection site. The final outcome of the events reported as complete recovery. The events were reported as non serious. Causality was not reported.
Age: 55.0
Sex: F
Vaccine: FLU3
Symptoms: Malaise, Pruritus
Clinical narrative: Case number PHHY2015US031934, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 556616) website on 16 Mar 2015. This report refers to a 55 year old female patient. Vaccination history included pneumococcal vaccine on an unknown date and experienced localized reaction at injection site of redness, swelling and hives on legs and trunk and physician did not prescribe a course of treatment. She had not sought out a physician, but had incidents noted in her medical records with her family physician. Historical drugs included extended release medications and serotonin reuptake inhibitors. Concomitant medications included gabapentin, oxycodone, ZANAFLEX, AMBIEN and LIDODERM patch 5%. She was vaccinated with FLUVIRIN (batch number: 66521011702) into the left arm (intramuscular) on 21 Nov 2011. 45 minutes after injection, the patient experienced general malaise and exhaustion which lasted about 18 hours. The patient experienced a reaction at injection site (itching, swelling and heat) and she had itching in left arm, at areas of head and scalp. She experienced localized area pain at injection site. The final outcome of the events reported as complete recovery. The events were reported as non serious. Causality was not reported.
Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Blister, Headache
Clinical narrative: Case number PHHY2015US029793, is an initial spontaneous report received for Vaccine Adverse Event Reporting System (VAERS reference number: 557267) website on 05 Mar 2015. This report refers to a 54-year-old female patient. The patient's concurrent condition included allergy to codeine. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 1410801) into the left arm intramuscularly on 23 Sep 2014. On 24 Sep 2014, the patient complained of blisters all over finger and face and had headache. The outcome of the events was reported as not recovered. The events were reported as non-serious. Causality was not reported.
Age: 46.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Erythema, Pain, Pyrexia, Swelling
Clinical narrative: Case number PHHY2015US032619, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 557287) website on 16 Mar 2015. This report refers to a 46-year-old male patient. Historical condition included pneumonia. Concomitant medications were none. He was vaccinated with FLUVIRIN (batch number: 1413801) intramuscularly into the left arm on 14 Nov 2014. On the same date, he was also vaccinated with PNEUMOVAX (batch number: K007262) intramuscularly into the left arm. On the same day, after vaccinations, the patient experienced fever, pain, redness and swelling. The patient required emergency room visit and was treated with unspecified antibiotic(s). The events were reported as non-serious. Outcome of the events was reported as recovered. Causality of the events was not reported.
Age: 39.0
Sex: F
Vaccine: FLU3
Symptoms: Drug administered at inappropriate site, Injection site pain
Clinical narrative: Case number PHHY2015US029904, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 558051) website on 05 Mar 2015. This report refers to a 39-year-old female patient. Her medical history and concomitant medication details was not reported. She was vaccinated with FLUVIRIN (batch number 1412501) intramuscularly into the deltoid muscle of right arm on 16 Oct 2014. On the same day after vaccination, she complained of pain when injected and afterwards. The patient was very bony and hence in order to reach muscle, the shot was given little higher than normal. No blood was seen at the injection site. The outcome of the events was not reported. The events was assessed as non-serious. The causality assessment of the events was not reported.
Age: 18.0
Sex: F
Vaccine: MNQ, TYP, YF
Symptoms: Axillary pain, Cold sweat, Flank pain, Hyperhidrosis, Injection site erythema
Clinical narrative: Case number PHHY2015US061117, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 560496) website on 12 May 2015. This report refers to an 18 years old female patient. Her concurrent conditions included cold and allergic to peanuts. She could not eat eggs without getting gastrointestinal upset, but now takes a pill and can now eat eggs without a problem. She was vaccinated with MENVEO (batch number: M14082) intramuscularly into left arm on 31 Dec 2014. On the same day, she was also vaccinated with VIVOTIF (batch number: 3000848, other manufacturer) oral and YF-VAX (batch number: UI121AA) subcutaneously into left arm. On the same day, after vaccinations, the patient experienced sore and tenderness at the injection site. On 01 Jan 2015, the patient had malaise, fever, sweating and felt clammy. These events resolved on 02 Jan 2015. On 02 Jan 2015, the patient started feeling pain down her arm, armpit, side and ribs. The patient described this pain as constant soreness. This sharp pain got progressively worsened with movement. On 05 Jan 2015, the patient felt a lump at the site of injection of the size of her hand. The lump was red and tender like a big bee sting. The pain on her torso and armpit was still present as of 05 Jan 2015. The patient's arm continued to be sore but now had started to pulse with movement. Outcome of other events was not reported. The case was assessed as non-serious. Causality of the events was not reported.
Age: 18.0
Sex: F
Vaccine: MNQ, TYP, YF
Symptoms: Injection site mass, Injection site pain, Malaise, Musculoskeletal chest pain, Pain
Clinical narrative: Case number PHHY2015US061117, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 560496) website on 12 May 2015. This report refers to an 18 years old female patient. Her concurrent conditions included cold and allergic to peanuts. She could not eat eggs without getting gastrointestinal upset, but now takes a pill and can now eat eggs without a problem. She was vaccinated with MENVEO (batch number: M14082) intramuscularly into left arm on 31 Dec 2014. On the same day, she was also vaccinated with VIVOTIF (batch number: 3000848, other manufacturer) oral and YF-VAX (batch number: UI121AA) subcutaneously into left arm. On the same day, after vaccinations, the patient experienced sore and tenderness at the injection site. On 01 Jan 2015, the patient had malaise, fever, sweating and felt clammy. These events resolved on 02 Jan 2015. On 02 Jan 2015, the patient started feeling pain down her arm, armpit, side and ribs. The patient described this pain as constant soreness. This sharp pain got progressively worsened with movement. On 05 Jan 2015, the patient felt a lump at the site of injection of the size of her hand. The lump was red and tender like a big bee sting. The pain on her torso and armpit was still present as of 05 Jan 2015. The patient's arm continued to be sore but now had started to pulse with movement. Outcome of other events was not reported. The case was assessed as non-serious. Causality of the events was not reported.
Age: 18.0
Sex: F
Vaccine: MNQ, TYP, YF
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Case number PHHY2015US061117, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 560496) website on 12 May 2015. This report refers to an 18 years old female patient. Her concurrent conditions included cold and allergic to peanuts. She could not eat eggs without getting gastrointestinal upset, but now takes a pill and can now eat eggs without a problem. She was vaccinated with MENVEO (batch number: M14082) intramuscularly into left arm on 31 Dec 2014. On the same day, she was also vaccinated with VIVOTIF (batch number: 3000848, other manufacturer) oral and YF-VAX (batch number: UI121AA) subcutaneously into left arm. On the same day, after vaccinations, the patient experienced sore and tenderness at the injection site. On 01 Jan 2015, the patient had malaise, fever, sweating and felt clammy. These events resolved on 02 Jan 2015. On 02 Jan 2015, the patient started feeling pain down her arm, armpit, side and ribs. The patient described this pain as constant soreness. This sharp pain got progressively worsened with movement. On 05 Jan 2015, the patient felt a lump at the site of injection of the size of her hand. The lump was red and tender like a big bee sting. The pain on her torso and armpit was still present as of 05 Jan 2015. The patient's arm continued to be sore but now had started to pulse with movement. Outcome of other events was not reported. The case was assessed as non-serious. Causality of the events was not reported.
Age: 11.0
Sex: F
Vaccine: FLUN4, HPV4, MNQ
Symptoms: Erythema, Local swelling, Pruritus
Clinical narrative: Case number PHHY2015US057914, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 561469) website on 12 May 2015. This report refers to a 11-year-old female patient. Her historical conditions and concomitant medication were none. On 12 Jan 2015, she was vaccinated with MENVEO (batch number: X14021) intramuscularly on left arm, FLUMIST QUADRIVALENT (other manufacturer, batch number: CK2057) and GARDASIL (other manufacturer, batch number: J010668 intramuscularly on right arm. On 13 Jan 2015, the patient experienced redness and swelling on left arm. On 14 Jan 2015, swelling had increased to 4 to 5 inches square and was itchy. The patient was seen by physician and was advised to give BENADRYL and apply ice to the area. Outcome of the events reported as recovered. Seriousness of the events reported as non serious. Causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: MENB, TDAP
Symptoms: Headache, Lethargy, Nausea, Syncope, Tremor
Clinical narrative: Case number PHHY2015US0606385, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 563772) website on 12 May 2015. This report refers to an 11-year-old male patient. Historical conditions were not reported. The patient had no current illness. No concomitant medication was reported. The patient was vaccinated with MENVEO (batch number: M14068) intramuscularly into the left arm, along with BOOSTRIX (batch number: 7535X) intramuscularly into the left arm on 05 Feb 2015. On the same day after vaccination, the patient experienced syncope, mild tremors, vomiting, nausea, headache and lethargy. The final outcome of the events was complete recovery. The events were reported as non-serious. Causality was not reported.
Age: 11.0
Sex: M
Vaccine: MENB, TDAP
Symptoms: Vomiting
Clinical narrative: Case number PHHY2015US0606385, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 563772) website on 12 May 2015. This report refers to an 11-year-old male patient. Historical conditions were not reported. The patient had no current illness. No concomitant medication was reported. The patient was vaccinated with MENVEO (batch number: M14068) intramuscularly into the left arm, along with BOOSTRIX (batch number: 7535X) intramuscularly into the left arm on 05 Feb 2015. On the same day after vaccination, the patient experienced syncope, mild tremors, vomiting, nausea, headache and lethargy. The final outcome of the events was complete recovery. The events were reported as non-serious. Causality was not reported.
Age: 48.0
Sex: F
Vaccine: MNQ
Symptoms: Arthralgia, Asthenia, Decreased appetite, Erythema, Fatigue
Clinical narrative: Case number PHHY2015US061580, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 565968) website on 12 May 2015. This report refers to a 48 years old female patient. Medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: M14067) intramuscularly on 23 Jan 2015. On 26 Jan 2015, the patient experienced decreased appetite, headache, joint pain, mild fever, muscle pain, tenderness, pain, redness, tiredness, weakness, pain in fingers and swelling at injection site. Outcome of the events was unknown. Case was assessed as non-serious. Causality of the events was not reported.
Age: 48.0
Sex: F
Vaccine: MNQ
Symptoms: Headache, Injection site swelling, Myalgia, Pain, Pain in extremity
Clinical narrative: Case number PHHY2015US061580, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 565968) website on 12 May 2015. This report refers to a 48 years old female patient. Medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: M14067) intramuscularly on 23 Jan 2015. On 26 Jan 2015, the patient experienced decreased appetite, headache, joint pain, mild fever, muscle pain, tenderness, pain, redness, tiredness, weakness, pain in fingers and swelling at injection site. Outcome of the events was unknown. Case was assessed as non-serious. Causality of the events was not reported.
Age: 48.0
Sex: F
Vaccine: MNQ
Symptoms: Pyrexia, Tenderness
Clinical narrative: Case number PHHY2015US061580, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 565968) website on 12 May 2015. This report refers to a 48 years old female patient. Medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: M14067) intramuscularly on 23 Jan 2015. On 26 Jan 2015, the patient experienced decreased appetite, headache, joint pain, mild fever, muscle pain, tenderness, pain, redness, tiredness, weakness, pain in fingers and swelling at injection site. Outcome of the events was unknown. Case was assessed as non-serious. Causality of the events was not reported.
Age: 11.0
Sex: F
Vaccine: MEN, MNQ
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Case number PHHY2015US062929, is an initial spontaneous report from a healthcare professional via Vaccine Adverse Event Reporting System (VAERS ID 567715) received on 12 May 2015.  This report refers to a 11-year-old female patient. Medical history and concomitant medications were not reported. She was vaccinated with first dose of MENVEO (batch number unknown) on 21 Jun 2007. She was vaccinated with second dose of meningococcal vaccine (manufacturer unknown, batch number unknown) on 20 Nov 2007 (inappropriate schedule of vaccine administered). She did not experience any adverse events. No further information was reported.
Age: 11.0
Sex: F
Vaccine: MEN, MNQ
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Case number PHHY2015US062929, is an initial spontaneous report from a healthcare professional via Vaccine Adverse Event Reporting System (VAERS ID 567715) received on 12 May 2015.  This report refers to a 11-year-old female patient. Medical history and concomitant medications were not reported. She was vaccinated with first dose of MENVEO (batch number unknown) on 21 Jun 2007. She was vaccinated with second dose of meningococcal vaccine (manufacturer unknown, batch number unknown) on 20 Nov 2007 (inappropriate schedule of vaccine administered). She did not experience any adverse events. No further information was reported.
Age: 16.0
Sex: F
Vaccine: MNQ
Symptoms: Erythema, Joint swelling, Peripheral swelling, Rash, Skin warm
Clinical narrative: Case number PHHY2015US062098, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 586725) website on 12 May 2015. This report refers to a 16 years old female patient. Medical history included acanthosis nigricans. Concomitant medications were not reported. She was vaccinated with MENVEO (batch number: U4680AA) intramuscularly into left arm on 30 Jan 2015. On 31 Jan 2015, the patient experienced rash along with redness and warmth on left arm. Further the patient experienced redness and swelling in wrists and hands bilaterally some redness on thighs. It was not itching and painful. The patient had a visit to emergency room due to these events. Outcome of the events was recovered. Case was assessed as non-serious. Causality of the events was not reported.
Age: 12.0
Sex: M
Vaccine: HPV4, MNQ
Symptoms: Dizziness, Pallor, Tinnitus
Clinical narrative: Case number PHHY2015US069682 is an initial spontaneous report from a healthcare professional via Vaccine Adverse Event Reporting System (VAERS ID 569682) received on 09 Jun 2015. This report refers to a 12-year-old male patient. Medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number A14094) in his left arm and GARDASIL (other manufacturer, batch number K009811) in his right arm on 18 Feb 2015. On the same date, he became dizzy, pale and complained of ringing in both ears about 10 min after receiving vaccines. The symptoms subsided about 10 min after onset. He was observed for 20 minutes. The final outcome of the events was recovered. The events were reported as non-serious. Causality was not reported.
Age: 11.0
Sex: U
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHEH2015US010941, is an initial spontaneous report received from a nurse on 05 Jun 2015. This report refers to an 11 year old patient of unknown gender. Historical condition and concomitant medication were not reported. The patient was vaccinated with MENVEO (batch number: M14068) intramuscularly on 03 Jun 2015. On 05 Jun 2015, the patient developed red, swollen, warm area at the injection site which sized like a softball. Final outcome of the events was condition unchanged. Seriousness and causality was not reported.
Sex: F
Vaccine: HPV4, HPV4, HPV4, HPV4, HPV4, HPV4
Symptoms: Death, Myocardial infarction, Pain, Seizure, Tachycardia
Clinical narrative: Information has been received from a physician via a company representative referring to a female patient of unknown age. Pertinent medical history and drug reactions/allergies were not reported. In approximately 2012 (reported as 3 to 4 years ago), the patient was vaccinated with GARDASIL (dose, route, lot# and expiration date were not reported). Concomitant drug was not reported. Shortly after starting the therapy, on an unknown date the patient experienced seizures. The patient sought medical attention for the seizures and was sent to multiple specialists. The patient passed away 2 or 3 weeks ago on approximately 22-JAN-2016 and the death was reported to be seizure related. It was unknown if an autopsy was done. Therapy with GARDASIL was not withdrawn. The causality was not reported. Upon internal review, the event of seizures was considered to be medically significant. Additional information has been requested.
Sex: F
Vaccine: HPV4, HPV4, HPV4, HPV4, HPV4, HPV4
Symptoms: Death, Feeding disorder, Generalised tonic-clonic seizure, Hyperacusis, Myocardial infarction
Clinical narrative: Information has been received from a physician via a company representative referring to a female patient of unknown age. Pertinent medical history and drug reactions/allergies were not reported. In approximately 2012 (reported as 3 to 4 years ago), the patient was vaccinated with GARDASIL (dose, route, lot# and expiration date were not reported). Concomitant drug was not reported. Shortly after starting the therapy, on an unknown date the patient experienced seizures. The patient sought medical attention for the seizures and was sent to multiple specialists. The patient passed away 2 or 3 weeks ago on approximately 22-JAN-2016 and the death was reported to be seizure related. It was unknown if an autopsy was done. Therapy with GARDASIL was not withdrawn. The causality was not reported. Upon internal review, the event of seizures was considered to be medically significant. Additional information has been requested.
Sex: F
Vaccine: HPV4, HPV4, HPV4, HPV4, HPV4, HPV4
Symptoms: Pain, Parenteral nutrition, Photophobia, Seizure, Tachycardia
Clinical narrative: Information has been received from a physician via a company representative referring to a female patient of unknown age. Pertinent medical history and drug reactions/allergies were not reported. In approximately 2012 (reported as 3 to 4 years ago), the patient was vaccinated with GARDASIL (dose, route, lot# and expiration date were not reported). Concomitant drug was not reported. Shortly after starting the therapy, on an unknown date the patient experienced seizures. The patient sought medical attention for the seizures and was sent to multiple specialists. The patient passed away 2 or 3 weeks ago on approximately 22-JAN-2016 and the death was reported to be seizure related. It was unknown if an autopsy was done. Therapy with GARDASIL was not withdrawn. The causality was not reported. Upon internal review, the event of seizures was considered to be medically significant. Additional information has been requested.
Sex: F
Vaccine: HPV4, HPV4, HPV4, HPV4, HPV4, HPV4
Symptoms: Vaccination complication
Clinical narrative: Information has been received from a physician via a company representative referring to a female patient of unknown age. Pertinent medical history and drug reactions/allergies were not reported. In approximately 2012 (reported as 3 to 4 years ago), the patient was vaccinated with GARDASIL (dose, route, lot# and expiration date were not reported). Concomitant drug was not reported. Shortly after starting the therapy, on an unknown date the patient experienced seizures. The patient sought medical attention for the seizures and was sent to multiple specialists. The patient passed away 2 or 3 weeks ago on approximately 22-JAN-2016 and the death was reported to be seizure related. It was unknown if an autopsy was done. Therapy with GARDASIL was not withdrawn. The causality was not reported. Upon internal review, the event of seizures was considered to be medically significant. Additional information has been requested.
Sex: F
Vaccine: HPV4, HPV4, HPV4, HPV4, HPV4, HPV4
Symptoms: Death, Fatigue, Inappropriate schedule of drug administration
Clinical narrative: Information has been received from a physician via a company representative referring to a female patient of unknown age. Pertinent medical history and drug reactions/allergies were not reported. In approximately 2012 (reported as 3 to 4 years ago), the patient was vaccinated with GARDASIL (dose, route, lot# and expiration date were not reported). Concomitant drug was not reported. Shortly after starting the therapy, on an unknown date the patient experienced seizures. The patient sought medical attention for the seizures and was sent to multiple specialists. The patient passed away 2 or 3 weeks ago on approximately 22-JAN-2016 and the death was reported to be seizure related. It was unknown if an autopsy was done. Therapy with GARDASIL was not withdrawn. The causality was not reported. Upon internal review, the event of seizures was considered to be medically significant. Additional information has been requested.
Sex: F
Vaccine: HPV4, HPV4, HPV4, HPV4, HPV4, HPV4
Symptoms: Death, Seizure
Clinical narrative: Information has been received from a physician via a company representative referring to a female patient of unknown age. Pertinent medical history and drug reactions/allergies were not reported. In approximately 2012 (reported as 3 to 4 years ago), the patient was vaccinated with GARDASIL (dose, route, lot# and expiration date were not reported). Concomitant drug was not reported. Shortly after starting the therapy, on an unknown date the patient experienced seizures. The patient sought medical attention for the seizures and was sent to multiple specialists. The patient passed away 2 or 3 weeks ago on approximately 22-JAN-2016 and the death was reported to be seizure related. It was unknown if an autopsy was done. Therapy with GARDASIL was not withdrawn. The causality was not reported. Upon internal review, the event of seizures was considered to be medically significant. Additional information has been requested.
Sex: F
Vaccine: HPV4, HPV4, HPV4, HPV4, HPV4, HPV4
Symptoms: Death, Gastrointestinal tube insertion, Pain
Clinical narrative: Information has been received from a physician via a company representative referring to a female patient of unknown age. Pertinent medical history and drug reactions/allergies were not reported. In approximately 2012 (reported as 3 to 4 years ago), the patient was vaccinated with GARDASIL (dose, route, lot# and expiration date were not reported). Concomitant drug was not reported. Shortly after starting the therapy, on an unknown date the patient experienced seizures. The patient sought medical attention for the seizures and was sent to multiple specialists. The patient passed away 2 or 3 weeks ago on approximately 22-JAN-2016 and the death was reported to be seizure related. It was unknown if an autopsy was done. Therapy with GARDASIL was not withdrawn. The causality was not reported. Upon internal review, the event of seizures was considered to be medically significant. Additional information has been requested.
Sex: F
Vaccine: HPV4, HPV4, HPV4, HPV4, HPV4, HPV4
Symptoms: Death, Myocardial infarction, Pain, Seizure, Tachycardia
Clinical narrative: Information has been received from a physician via a company representative referring to a female patient of unknown age. The patient's medical history, concurrent conditions and drug reactions/allergies were not reported. In approximately 2012 (reported as "about 3 or 4 years ago"), the patient was vaccinated with GARDASIL (dose, route, lot# and expiration date unknown). In approximately 2012, the patient started experiencing "seizures" shortly after starting therapy with GARDASIL. The patient sought medical attention for the "seizures" and was "sent to multiple specialists". The patient passed away in approximately January 2016 (reported as "2 or 3 weeks ago") and the death was reported to be "seizure related". The relatedness between the event and GARDASIL was not provided. Upon internal review, the event seizures were considered to be medically significant. Additional information has been requested.
Sex: F
Vaccine: HPV4, HPV4, HPV4, HPV4, HPV4, HPV4
Symptoms: Death, Feeding disorder, Generalised tonic-clonic seizure, Hyperacusis, Myocardial infarction
Clinical narrative: Information has been received from a physician via a company representative referring to a female patient of unknown age. The patient's medical history, concurrent conditions and drug reactions/allergies were not reported. In approximately 2012 (reported as "about 3 or 4 years ago"), the patient was vaccinated with GARDASIL (dose, route, lot# and expiration date unknown). In approximately 2012, the patient started experiencing "seizures" shortly after starting therapy with GARDASIL. The patient sought medical attention for the "seizures" and was "sent to multiple specialists". The patient passed away in approximately January 2016 (reported as "2 or 3 weeks ago") and the death was reported to be "seizure related". The relatedness between the event and GARDASIL was not provided. Upon internal review, the event seizures were considered to be medically significant. Additional information has been requested.
Sex: F
Vaccine: HPV4, HPV4, HPV4, HPV4, HPV4, HPV4
Symptoms: Pain, Parenteral nutrition, Photophobia, Seizure, Tachycardia
Clinical narrative: Information has been received from a physician via a company representative referring to a female patient of unknown age. The patient's medical history, concurrent conditions and drug reactions/allergies were not reported. In approximately 2012 (reported as "about 3 or 4 years ago"), the patient was vaccinated with GARDASIL (dose, route, lot# and expiration date unknown). In approximately 2012, the patient started experiencing "seizures" shortly after starting therapy with GARDASIL. The patient sought medical attention for the "seizures" and was "sent to multiple specialists". The patient passed away in approximately January 2016 (reported as "2 or 3 weeks ago") and the death was reported to be "seizure related". The relatedness between the event and GARDASIL was not provided. Upon internal review, the event seizures were considered to be medically significant. Additional information has been requested.
Sex: F
Vaccine: HPV4, HPV4, HPV4, HPV4, HPV4, HPV4
Symptoms: Vaccination complication
Clinical narrative: Information has been received from a physician via a company representative referring to a female patient of unknown age. The patient's medical history, concurrent conditions and drug reactions/allergies were not reported. In approximately 2012 (reported as "about 3 or 4 years ago"), the patient was vaccinated with GARDASIL (dose, route, lot# and expiration date unknown). In approximately 2012, the patient started experiencing "seizures" shortly after starting therapy with GARDASIL. The patient sought medical attention for the "seizures" and was "sent to multiple specialists". The patient passed away in approximately January 2016 (reported as "2 or 3 weeks ago") and the death was reported to be "seizure related". The relatedness between the event and GARDASIL was not provided. Upon internal review, the event seizures were considered to be medically significant. Additional information has been requested.
Sex: F
Vaccine: HPV4, HPV4, HPV4, HPV4, HPV4, HPV4
Symptoms: Death, Fatigue, Inappropriate schedule of drug administration
Clinical narrative: Information has been received from a physician via a company representative referring to a female patient of unknown age. The patient's medical history, concurrent conditions and drug reactions/allergies were not reported. In approximately 2012 (reported as "about 3 or 4 years ago"), the patient was vaccinated with GARDASIL (dose, route, lot# and expiration date unknown). In approximately 2012, the patient started experiencing "seizures" shortly after starting therapy with GARDASIL. The patient sought medical attention for the "seizures" and was "sent to multiple specialists". The patient passed away in approximately January 2016 (reported as "2 or 3 weeks ago") and the death was reported to be "seizure related". The relatedness between the event and GARDASIL was not provided. Upon internal review, the event seizures were considered to be medically significant. Additional information has been requested.
Sex: F
Vaccine: HPV4, HPV4, HPV4, HPV4, HPV4, HPV4
Symptoms: Death, Seizure
Clinical narrative: Information has been received from a physician via a company representative referring to a female patient of unknown age. The patient's medical history, concurrent conditions and drug reactions/allergies were not reported. In approximately 2012 (reported as "about 3 or 4 years ago"), the patient was vaccinated with GARDASIL (dose, route, lot# and expiration date unknown). In approximately 2012, the patient started experiencing "seizures" shortly after starting therapy with GARDASIL. The patient sought medical attention for the "seizures" and was "sent to multiple specialists". The patient passed away in approximately January 2016 (reported as "2 or 3 weeks ago") and the death was reported to be "seizure related". The relatedness between the event and GARDASIL was not provided. Upon internal review, the event seizures were considered to be medically significant. Additional information has been requested.
Sex: F
Vaccine: HPV4, HPV4, HPV4, HPV4, HPV4, HPV4
Symptoms: Death, Gastrointestinal tube insertion, Pain
Clinical narrative: Information has been received from a physician via a company representative referring to a female patient of unknown age. The patient's medical history, concurrent conditions and drug reactions/allergies were not reported. In approximately 2012 (reported as "about 3 or 4 years ago"), the patient was vaccinated with GARDASIL (dose, route, lot# and expiration date unknown). In approximately 2012, the patient started experiencing "seizures" shortly after starting therapy with GARDASIL. The patient sought medical attention for the "seizures" and was "sent to multiple specialists". The patient passed away in approximately January 2016 (reported as "2 or 3 weeks ago") and the death was reported to be "seizure related". The relatedness between the event and GARDASIL was not provided. Upon internal review, the event seizures were considered to be medically significant. Additional information has been requested.
Age: 1.4
Sex: F
Vaccine: DTAPIPVHIB, HEPAB, PPV
Symptoms: Crying, Injection site rash, Rash, Rash erythematous, Swelling face
Clinical narrative: Red Bumps raised almost looked like small hives or rash of some kind.  Her face looked puffy but she did cry for an hour.
Age: 72.0
Sex: F
Vaccine: PPV
Symptoms: Cellulitis, Local reaction, Skin warm, Tenderness
Clinical narrative: Pt presented to clinic the following day w/ 6 cm in width almost circumfrential area around L upper arm w/ associated warmth, TTP consistent w/ very large local rxn vs cellulitis. Pt was afebrile and w/o any difficulties breathing, managing secretions, other rash, vomiting or diarrhea.
Age: 72.0
Sex: M
Vaccine: FLUX, FLUX
Symptoms: Muscular weakness
Clinical narrative: I don't remember the exact date or time. General weakness in right arm especially when twisting or lifting it. No treatment. I am just waiting for it to feel better. I doesn't yet.
Age: 78.0
Sex: M
Vaccine: FLU3, PNC13
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Documented vaccines were exact duplications of vaccinations that patient received at medical center prior to admission to medical center where duplicate vaccines were given prior to discharge. Influenza vaccination given on 09/25/2015 and PREVNAR 13 given on 06/25/14 at medical center. Patient is not known to have suffered any adverse reactions to duplicate vaccination with both influenza and PREVNAR 13.
Age: 38.0
Sex: M
Vaccine: FLUX, FLUX
Symptoms: Dyspnoea, Pruritus, Swelling face, Urticaria
Clinical narrative: Woke up to severe itching located at hands and feet. Hives began to develop and facial swelling began. Labored breathing shortly after. Treatment at the ER was epi shot, plus several others.